Navigation Links
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
Date:4/1/2009

e requirements of the FDA or other regulatory agencies; and risks related to the conduct of Sunesis' clinical trials and manufacturing. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, Current Report on Form 8-K anticipated to be filed on the date of this press release and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.

    Investor Contact:
    Sunesis Pharmaceuticals, Inc.
    Eric Bjerkholt
    650-266-3717

    Media Contact:
    Sunesis Pharmaceuticals, Inc.
    Dan Weinseimer
    650-266-3739

                        SUNESIS PHARMACEUTICALS, INC.
                         CONSOLIDATED BALANCE SHEETS

                                               December 31   December 31
                                                   2008          2007
                                                   ----          ----
    ASSETS                                                     (Note 1)

    Current assets:
      Cash and cash equivalents                $6,296,942   $11,726,126
      Marketable securities                     4,321,844    35,957,933
      Prepaids and other current assets           934,429       945,583
                                                  -------       -------
    Total current assets                       11,553,215    48,629,642

    Property and equipment, net                   612,241     4,238,498
    Asse
'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
2. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
4. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
5. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
6. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
7. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
8. Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008
9. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
10. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
11. Sunesis to Present at Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... , ... The global aptamers market is expected to reach ... of 17.89% between 2015 and 2020. The aptamer type segments included in this ... report is segmented into diagnostics, therapeutics development, R&D, and other applications. Diagnostics applications ...
(Date:7/7/2015)... Wilmington, DE (PRWEB) , ... July 07, 2015 ... ... organizations that work together to lower barriers to innovation in life science R&D, ... additions in the last quarter include another top ten pharmaceutical company joining as ...
(Date:7/6/2015)... 6, 2015  Approximately 1% of the population inherits ... chromosomes. These individuals are three times more likely to ... one of the nation,s leading medical journals by researchers ... Photo - http://photos.prnewswire.com/prnh/20150706/230685 ... causes roseola (also known as "sixth disease") and occasional ...
(Date:7/6/2015)... SUNNYVALE, Calif. , July 6, 2015  Viveve Medical, ... announced that Patricia Scheller , Viveve,s Chief Executive Officer, ... present live at VirtualInvestorConferences.com on July 9, 2015. , ... 9, 2015 , , , , TIME:     ... , LINK: , , , http://tinyurl.com/viveve   , ...
Breaking Biology Technology:Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 2Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 3Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 4Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 5Pistoia Alliance Continues to Attract New Members 2Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 2Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 3Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3
... 2012 PAC more accurately tracks true ... provider, Elsevier/Gold Standard , announced today an agreement with ... of a new price type, Predictive Acquisition Cost (PAC). ... need for a pricing standard that more closely tracks true ...
... Sales Performance, a global sales support organization providing consulting, ... $4 million to purchase and relocate to an expanded ... corridor. The company expects to create over 200 new ... next five years. In addition, through an innovative incentive ...
... The American Botanical Council (ABC) has announced the ... Literature Award in the reference and technical book category. ... of Botanical Medicines (CRC Press, 2011), has been ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The ABC James ...
Cached Biology Technology:Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type 2Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type 3City of Mason and Top Gun Sales Performance Announce $4 Million Investment In New Corporate Headquarters 2Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 2Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 3Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 4Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 5
(Date:7/7/2015)... DUBLIN , June 30, 2015 ... ) has announced the addition of the ... their offering. To this date, fingerprint ... biometric technology and fingerprint sensors are well developed. ... capacitive sensing technology. The domain of ...
(Date:7/7/2015)... VIEW, Calif. , July 7, 2015 /PRNewswire/ ... biometrics market, Frost & Sullivan recognizes Credence ID, ... Sullivan Entrepreneurial Company of the Year Award. ... suite to aid in its mission of offering ... under-recognized populations globally. As Credence ID was formed ...
(Date:7/7/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... market announces a revised version of one of its first 30 ... on CNBC in New York , ... San Francisco metro areas.    , ... to replace all the cards in your wallet and keep your ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... when one master gene actually suppresses the action of ... report that appears online in the journal Proceedings of ... of bone and cartilage cells that are differentiated from ... associate professor of molecular and human genetics at BCM, ...
... stroke in the U.S. over the past 50 years has ... a study in the December 27 issue of JAMA. , ... more than 750,000 new strokes occurring each year in the ... behind heart disease and cancer and the leading neurologic cause ...
... multiplied and differentiated into brain cells on a new ... more like a living body than any other cell ... will report the invention-which may one day replace the ... issue of the PLoS ONE. Shuguang Zhang, associate director ...
Cached Biology News:Signaling for cartilage 2Incidence of stroke decreases over last 50 years 2MIT creates 3-D scaffold for growing stem cells 2MIT creates 3-D scaffold for growing stem cells 3
... has established an expertise in the forefront ... solid support synthesis and synthesis in solution. ... Mass Spectrometry and analytical HPLC at no ... that meet the highest quality standard. , ...
... Labsystems' Wellwash AC is the ... washer available, and is provided ... wash, waste and rinse bottles. ... automatic rinsing and priming functions ...
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use. This advanced microplate washer meets the exacting standards of today's assay requirements....
... engineered endonuclease. This unique enzyme degrades all ... no proteolytic activity. It is effective over ... an exceptionally high specific activity. Ideal for ... its use enables compliance with FDA guidelines ...
Biology Products: